FrieslandCampina gets green light for its human milk oligosaccharide ingredient from regulatory authorities

May 8, 2018 | News Commentary

FrieslandCampina has recently obtained EU approval as well as GRAS status from the FDA for its human milk oligosaccharide (HMO) ingredient, 2′-fucosyllactose (2′-FL), closely following the recent approval obtained by...

Login to View This Research

Already a Lux Client?

Sign In

Not a Lux Client?

Talk to Lux Research now and learn the benefits of becoming a member.

Lux Research

  • Helps clients find new business opportunities from emerging technologies in the physical and life sciences
  • Offers ongoing technology and market intelligence, as well as market data and consulting services
  • Now serves over 250 clients on six continents – multinational corporations, investors, governments, and SMEs
  • Has a Global reach, with offices in Boston, New York, Amsterdam, Singapore, and Tokyo
  • Combines deep technical expertise with business analysis to support strategic decisions

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 (0) 20-3460840

For APAC (Singapore)
+65 6592-6978